Amdocs Limited (NASDAQ:DOX) Receives $101.20 Consensus Target Price from Analysts

Shares of Amdocs Limited (NASDAQ:DOX) have been assigned a consensus recommendation of “Moderate Buy” from the five brokerages that are currently covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 1-year price objective among brokers that have covered the stock in the last year is $101.20.

Several equities research analysts recently commented on DOX shares. Barclays dropped their price objective on shares of Amdocs from $113.00 to $111.00 and set an “overweight” rating on the stock in a research note on Thursday, November 14th. Oppenheimer upped their price target on Amdocs from $98.00 to $105.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 13th. Stifel Nicolaus started coverage on Amdocs in a research note on Wednesday, October 2nd. They set a “buy” rating and a $100.00 price objective for the company. Finally, StockNews.com cut Amdocs from a “strong-buy” rating to a “buy” rating in a research note on Thursday, November 14th.

Amdocs Stock Performance

Shares of DOX stock opened at $87.01 on Monday. The company’s fifty day moving average price is $87.93 and its 200-day moving average price is $84.75. The stock has a market cap of $10.23 billion, a PE ratio of 20.52, a price-to-earnings-growth ratio of 1.45 and a beta of 0.72. The company has a current ratio of 1.20, a quick ratio of 1.24 and a debt-to-equity ratio of 0.21. Amdocs has a 12 month low of $74.41 and a 12 month high of $94.04.

Amdocs Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be issued a dividend of $0.479 per share. This represents a $1.92 dividend on an annualized basis and a dividend yield of 2.20%. The ex-dividend date is Tuesday, December 31st. Amdocs’s payout ratio is currently 45.05%.

Institutional Investors Weigh In On Amdocs

Large investors have recently bought and sold shares of the business. Private Trust Co. NA lifted its stake in Amdocs by 62.9% during the 3rd quarter. Private Trust Co. NA now owns 303 shares of the technology company’s stock valued at $27,000 after acquiring an additional 117 shares during the period. Brooklyn Investment Group purchased a new stake in Amdocs in the third quarter worth approximately $28,000. Catalyst Capital Advisors LLC purchased a new stake in Amdocs in the third quarter worth approximately $55,000. GAMMA Investing LLC grew its position in Amdocs by 115.1% in the 3rd quarter. GAMMA Investing LLC now owns 800 shares of the technology company’s stock worth $70,000 after purchasing an additional 428 shares during the period. Finally, American National Bank purchased a new stake in Amdocs during the 2nd quarter valued at $76,000. 92.02% of the stock is currently owned by institutional investors.

Amdocs Company Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.